Loading…

DURABLE REMISSION DURATION OF RESPONSE (%) TIME (MONTHS) 100 80 60 20 0 0 3 6 9 12 15 18 21 24 27 30 - Owned by Kite Pharma, Inc. - (Class 035, Class 044) | Sealvo